Image
To mitigate nonadherence for inflammatory condition treatments, plan sponsors should adopt a multifaceted approach that combines clinical protocols and value-based solutions.
Data shows that the greatest rates of price increase happened when rebates were at their lowest.
An analysis of 2022 Express Scripts data has found that members are paying less at the pharmacy counter.